Funded Tech Companies
TORL BioTherapeutics
Wondering who provided funding to TORL BioTherapeutics? Blue Owl Capital, UC Investments and Moore Strategic Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
TORL BioTherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
TORL BioTherapeutics is a clinical-stage bi ©pharmaceutical business. Operator of a drug development company intended to accelerate pre-clinical drug discovery. The company offers combined UCLA's slamon drug screening with Caltech's Stoltz chemistry platform in order to identify targets with clinical success, enabling researchers to develop proprietary drugs with unique and optimized profiles.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/10/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Licata
Co-Founder
Mark Alles
Co-Founder
Dennis Slamon
Company Investors
- Blue Owl Capital
- UC Investments
- Moore Strategic Ventures
- Avidity Partners
- RA Capital Management
- Perceptive Xontogeny Venture Fund
- Deep Track Capital
- Bristol Myers Squibb
- Vertex Ventures HC
- Perceptive Advisors
- Goldman Sachs
- Alexandria Venture Investments
- Cowen Healthcare Investments
- OCV Partners
Browse more funded tech companies:
Torii | Tornado Spectral Systems
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs